Pathology News

Digital Pathology and AI Congress: Europe 2026
2026-12-09 - 2026-12-10 | Novotel London West, 1 Shortlands, Hammersmith, London, W6 8DR, United Kingdom
0000Days00Hrs00Min00SecThis internationally recognised meeting brings together 600+ attendees and 60+ technology providers to discuss and collaborate on the latest advances, developments and case studies in the Digital Pathology & AI field. As digital workflows become the norm, the focus now turns to refining digital workflows and how the future of Digital Pathology & AI may lead us to precision medicine approaches for disease treatment.
As a part of the 2025 meeting, attendees discovered how to overcome potential challenges with LIMS and digital workflows, learned about Digital Pathology and AI integration in clinical trials and found out about the return on investment when implementing Digital Pathology. Plus, we explored AI regulation and the ethics of using the technology.
At the heart of our conference lies an unparalleled opportunity to connect. With over seven hours dedicated exclusively to networking, participants have the time and space to engage deeply with peers, share ideas, and spark meaningful collaborations. These interactions are where breakthroughs begin — fostering connections that drive collaborative innovation and discovery.
Register Now

9th Annual Meeting: Association of Breast Pathology
2026-11-27 00:00 - 2026-11-28 00:00 (Europe/London) | The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE, United Kingdom
0000Days00Hrs00Min00Sec

It’s a great opportunity to learn from experts, share experiences and connect with colleagues from across the field.

Join the Association of Breast Pathology for one and a half days of engaging talks, practical lectures, case-based discussions and the latest updates in breast pathology.

Programme Highlights

WHO guidelines update
Update on fibroepithelial lesions
How to score Ki-67
Triple negative and ER-low breast cancer
Everyday dilemmas in breast pathology
and much more…

Register Now

Path360 2026: The Convenzis NHS Pathology Strategy Conference Midlands
2026-11-04 08:30 - 18:30 (Europe/London) | The Studio, 3rd Floor, Birmingham, 3rd Floor, 7 Cannon St, Birmingham, B2 5EP, United Kingdom
0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences
Pathology services are integral to the NHS, supporting over 70% of clinical diagnoses. As demands on pathology continue to grow, innovation in digital pathology, automation, and workforce management is essential. This conference will explore the latest advancements and strategies for ensuring efficiency, accuracy, and service sustainability.
Key Topics:

Digital pathology and AI-driven diagnostics
Addressing staff shortages and training needs
The future of pathology networks
Improving turnaround times and service integration
Investment and funding for pathology services

Register NowWhy Attend?
This annual event brings together NHS pathology professionals, laboratory managers, and clinical leaders to explore cutting-edge developments in diagnostics. Join the conversation and be part of shaping the future of pathology services.

Med4Nexus Exhibition & Summit UK 2026
2026-11-04 - 2026-11-05 | QEII Centre, London, UK, London, United Kingdom
0000Days00Hrs00Min00SecWhere Biotech, AI, Digital Health & Connected Care Converge
The integrated healthcare event tracing the complete patient pathway, from molecular diagnostics through clinical intelligence to targeted treatment.
Over two days, connect with 2,500+ NHS decision-makers, laboratory directors, digital health executives, clinicians, academia, pathologists, biopharma leaders and investors.
Healthcare is at a pivotal moment. Innovation in biotechnology, AI, digital health, and connected care is converging amid rapid system digitisation, growing investment, and workforce pressures. Med4Nexus provides the platform where healthcare leaders, laboratories, and innovators collaborate to share insight and accelerate technologies that deliver real-world impact for patients and providers.
Register NowConference Themes & Format
At the heart of Med4Nexus Exhibition & Summit is a CPD-accredited conference programme featuring a main stage, breakout sessions and specialist side events, all designed to examine how new tools, diagnostics, digital platforms and therapeutic innovations perform within real clinical environments. The programme focuses on how innovation enhances patient outcomes, strengthens diagnostic pathways, streamlines operational performance and supports service redesign; bridging the gap between emerging solutions and real-world implementation across the NHS.

UK NEQAS Annual Participant Meeting 2026
2026-11-03 | America Square, London, United Kingdom
0000Days00Hrs00Min00SecThe UK NEQAS CPT Annual Participant Meeting brings together cellular pathology professionals, laboratory scientists, and quality assurance experts to explore the latest developments in external quality assessment (EQA), laboratory best practice, and diagnostic innovation. The meeting provides an opportunity for participants to hear updates from the UK NEQAS CPT team, learn about emerging techniques and technologies, and gain practical insights from keynote speakers working across the field of cellular pathology.
Alongside the scientific programme, the event encourages discussion, knowledge sharing, and networking between laboratories, industry partners, and healthcare professionals, supporting continuous professional development and the ongoing improvement of quality standards in diagnostic pathology.
Register Now

ASDP 2026 Singapore | Asian Society of Digital Pathology 3rd Annual Congress
2026-11-01 - 2026-11-03 | Academia, Singapore General Hospital, 20 College Rd, Singapore, 169856, Singapore
0000Days00Hrs00Min00SecBringing together forward-thinking pathologists, researchers, healthcare executives, and solution providers from across Asia and beyond – hosted in Singapore in November 2026.
Intelligence in Every Pixel: Powering Next Generation Pathology
Annual Congress of the Asian Society of Digital Pathology (ASDP) serves as a unique platform where leaders in digital pathology, computational science, clinical practice, and industry innovation converge.
Building on the success of the first congress in Seoul (2024) and the second congress in Mumbai (2025), the third congress in Singapore in 2026 will bring together pathologists, computer scientists, researchers, industry and policy makers from across the world to explore the latest advances in digital pathology, artificial intelligence, computational imaging and precision diagnostics.
Register NowASDP 2026 is proudly hosted by the Singapore Division of the International Academy of Pathology (SGIAP) and SingHealth Pathology Academic Clinical Programme (SingHealth PATH ACP).

ESOI Touchdown 2026
2026-10-29 - 2026-10-31 | DKFZ Heidelberg, Im Neuenheimer Feld 280, Heidelberg, 69120, Germany
0000Days00Hrs00Min00Sec
ESOI Touchdown 2026 brings together radiologists, clinicians, scientists, patients, and industry partners, the meeting will explore the latest advances in oncologic imaging.
The scientific programme will cover a wide range of topics, including artificial intelligence, innovative imaging strategies, multidisciplinary cancer care, cancer screening, therapy-related toxicities, and the future of oncologic reporting. Alongside expert presentations, attendees can take part in interactive workshops and multidisciplinary case discussions, providing valuable opportunities for practical learning, collaboration, and networking within the international oncology imaging community.

Register Now

Highlights

Signal to Decision: How AI Is Transforming Radiology into the Engine of Integrated Oncologic Diagnostics
Keynote Lecture: Individualising Oncologic Diagnostics: The Transformative Power of Liquid Biopsy
Cancer of Unknown Primary – Imaging at the Diagnostic Frontier
Stop Writing Novels: The Future of Radiology Reporting
Bridging Science and Care: Partnership of Patients, Clinicians and Scientists
Neuroendocrine Tumors
Innovations in Cancer Screening
Dark side of the Treatment: Imaging Toxicities of Contemporary Cancer Therapy

MDT Sessions

Lung Cancer MDT
Urogenital Cancer MDT
Gynecological Oncology MDT

Workshops

MRI Characterization of Ovarian Masses
Bone Metastasis & Their Mimics
Imaging in Hematologic Malignancies
Patient Communication for Radiologists
Primary Liver Malignancies: Imaging for Detection and Treatment Planning
Challenges in Head & Neck Imaging
Prostate Cancer: From PI-RADS to Individualized Care
Communication of Scientific Results: How to present yourself

ESMO Congress 2026
2026-10-23 - 2026-10-27 | IFEMA MADRID, Avda. Del Partenón, 5, Madrid, 28042, Spain
0000Days00Hrs00Min00SecThe ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care.
Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.
Register NowA comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science, highlight the first announcements of potentially practice-changing data, and stimulate multidisciplinary discussions aimed at improving treatment options for patients.
Learning objectives

To stay informed about current approaches in cancer prevention, screening, and early detection
To gain insights into the latest advances in basic, translational, and clinical cancer research
To explore the clinical implications of scientific breakthroughs in cancer biology, diagnostics, and treatment
To be updated on state-of-the-art therapeutic strategies for patients with cancer
To examine the emerging role of artificial intelligence in cancer diagnosis, research and therapy

Pathology Visions 26
2026-10-16 - 2026-10-18 | Manchester Grand Hyatt, San Diego, United States
0000Days00Hrs00Min00SecElevate Patient Care: Discover the Power of DP & AI
Pathology Visions unites 1,000+ digital pathology experts and peers tackling today’s challenges and shaping tomorrow’s innovations.
Engage in practical discussions, explore real-world applications, and gain actionable insights you can implement immediately.
Whether you’re a seasoned expert or an emerging professional, PathVisions offers a collaborative platform for learning and growth.
Don’t just keep up with change, lead it. Discover your place at PathVisions.
Register Now

4th Spatial Biology Congress: Asia 2026
2026-10-13 - 2026-10-14 | Lee Kong Chian School of Medicine – NTU Singapore (Novena Campus), Singapore
0000Days00Hrs00Min00SecThe 4th Spatial Biology Congress Asia brings together leaders in spatial biology, imaging, bioinformatics, and multi-omics technologies to explore the latest methods and applications transforming biological insights and translational medicine.
Over two days, delegates will benefit from expert-led presentations, panel discussions, and interactive sessions focused on the latest innovations in spatial biology, from high-plex imaging and complex datasets to cutting-edge analysis pipelines. The programme will also explore how these advances are supporting biomarker discovery, disease research, and clinical applications.
Why Attend?

Gain insights from leading researchers, clinicians and industry innovators sharing the latest breakthroughs in the field of spatial biology
Exposure to the latest advances in spatial transcriptomics, proteomics, and imaging have transformed translational medicine
Case studies demonstrating how spatial data informs disease stratification, biomarker validation, and clinical workflows
Connect with fellow peers, and solution providers through interactive sessions, panel discussions, and dedicated networking opportunities to foster collaboration

Register Now

Biomarkers, CDx & Precision Medicine Europe 2026
2026-10-13 - 2026-10-14 | Congress Center Basel, Messeplatz 21, Basel, CH-4058, Switzerland
0000Days00Hrs00Min00SecA new pathway to patient impact.
Targeted therapies are reframing the outlook for human health creating unprecedented scope for life-changing targeted treatments.
Are you ready to participate in this shared opportunity? Do you have the knowledge, strategy, tools and connections in place?
Precision Medicine provides the platform for you to learn, engage and collaborate across the entire targeted therapy R&D ecosystem — an interdisciplinary community of specialists in pharma, biotech, academia and healthcare.
The event will feature three core programs:

Biomarkers & Companion Diagnostics– Focusing on the discovery, validation, and application of biomarkers in personalized healthcare.
Spatial Biology for Precision Medicine – Highlighting the importance of spatial insights in the development of precision therapies.
Computational Pathology & AI for Precision Diagnostics– Exploring the integration of digital pathology and artificial intelligence in transforming clinical diagnostics.

Register Now

Why attend?

Expand your knowledge
Let subject specialists take you further and deeper.
With comprehensive learning in oncology, neuroscience and key complementary areas.
Build the partnerships you need
Identify, meet and collaborate with the people your strategy requires.
Start working with those who share your goals with 200 hours of pre-arranged 1-2-1s.
Join the conversation
Meet like-minded peers, expand your network and engage in interdisciplinary discussion on the latest thinking and practice.
See what’s in the pipeline
Our events are where innovations land.
Be at the showcase and meet the people behind technologies to give you the edge.
Understand the competitive landscape
Learn what others in your field are doing.
Evaluate their successes (and failures) and set your own benchmarks.
Harness AI & machine learning
AI & machine-learning tools will be critical in unlocking growth.
See the technology in action and speak to those who can help you implement it.

CancerCare 2026: The NHS Oncology Conference
2026-10-06 08:30 - 18:30 UTC | etc.venues, Prospero House, London, 241 Borough High St, London, SE1 1GA, United Kingdom
0000Days00Hrs00Min00SecClinical Diagnostics & Medical SciencesA Strategic Conference on Advancing Oncology Pathways Across the NHS – All Convenzis Events Provide 8 CPD Points Per DelegateCancer remains one of the NHS’s most complex and urgent challenges demanding faster diagnosis, more equitable access to treatment, and a workforce confident in delivering precision care. The 10 Year Health Plan places early detection, innovation, and personalisation at the heart of future oncology services.
The NHS Oncology Conference provides a strategic forum for leaders to address these challenges together, translating policy ambition into practical delivery. This event brings NHS teams, ICSs, and cancer alliances together to exchange tested models, frameworks, and collaborative solutions to strengthen early detection, scale genomics, and integrate personalised oncology care within community settings.
Register NowSummit Focus:The NHS Oncology Conference is a premier event for sharing best practices and innovations, designed to help NHS professionals move from awareness to applied implementation. Delegates will gain hands-on frameworks, tested delivery models, and peer-derived insights on how to embed safe, equitable, and sustainable transformation within their services.
Dedicated Skill Clinics offer practical tools, checklists, and implementation templates to support cancer pathway redesign, genomic testing integration, and workforce capability development.
Lessons Learned Sessions provide candid reflections from NHS leaders on real-world challenges, highlighting where implementation plans required adjustment and what delivered measurable results.
This is not a showcase of what to achieve, but a skills exchange on how to achieve it, translating national ambition into measurable improvement.
This year’s event is structured around clear outcomes. Delegates will leave understanding:

Enhance early detection through targeted screening, self-sampling, and expanded genetic testing.
Accelerate innovation by adopting technologies like cancer vaccines, liquid biopsies, and whole genome sequencing.
Advance personalised care using genomics and AI to guide tailored treatments.
Expand community-based oncology, integrating diagnostics, rehab, and follow-up care into local health centres.
Strengthen resilience through digital transformation, workforce capability, and robust governance.
Improve access and equity across cancer pathways, including prostate cancer and haematology services.

What’s New for 2026:
Morning & Afternoon Skill Clinics: immersive sessions focused on actionable tools, checklists, and templates delegates can implement immediately within oncology services.
Lessons Learned Sessions: real-world reflections from NHS leaders detailing what went wrong, what changed, and what succeeded in implementing cancer pathway transformation.
Peer Learning Circles: small-group exchanges enabling collaboration between cancer alliances, ICBs, and provider teams to co-design practical solutions.
Action-Driven Case Studies: focusing on the delivery process — how genomic testing, data integration, and workforce innovation created measurable outcomes.

Why Attend:
Earn 8 CPD Points by attending.
Build professional confidence through applied, hands-on learning.
Access ready-to-use frameworks for early detection, genomic integration, and pathway transformation.
Hear directly from NHS leaders and peers driving oncology service improvement.
Leave with practical artefacts, toolkits, and implementation plans ready for local rollout.
Join a national community of NHS professionals committed to capability-building and sustainable cancer care delivery.

Who Would Benefit:This conference is ideal for clinical, operational, and strategic leaders involved in oncology transformation, including Cancer Alliance leads, oncology service managers, diagnostic and genomic programme directors, Chief Nurses, CCIOs, CIOs, AHP leads, and ICB or ICS transformation teams. It will also benefit commissioners, community health directors, and primary care leaders seeking practical guidance on scalable, interoperable models of cancer care.
Suppliers, research partners, and technology collaborators will gain insight into NHS oncology priorities, workforce capability needs, and the practical enablers shaping the next decade of personalised cancer care.

CancerCare 2026: The Convenzis NHS Oncology Conference
2026-10-06 08:30 - 18:30 UTC | The Studio, 3rd Floor, Birmingham, 3rd Floor, 7 Cannon St, Birmingham, B2 5EP, United Kingdom
0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences
A Learning-Focused Summit on NHS Oncology
Cancer remains one of the NHS’s most complex and urgent challenges demanding faster diagnosis, more equitable access to treatment, and a workforce confident in delivering precision care. The 10 Year Health Plan places early detection, innovation and personalisation at the heart of future oncology services. This summit responds directly to that call, providing the education, skills and tools NHS professionals need to deliver cancer care that is proactive, personalised and closer to home.
Educational Focus:
Through a mix of Skill Clinics, Lessons Learned Sessions, and Peer Learning Circles, delegates will learn using real-world frameworks, tools, and templates to strengthen early detection pathways, expand genomic testing, and deliver community-based oncology care.
The focus is not on what to achieve, but how to achieve it. Senior leaders and clinicians will share first-hand insights on implementation challenges, course corrections and replicable improvement models that can be applied immediately within local systems.
Key Topics:

Expanding targeted screening, self-sampling and early detection initiatives.
Scaling genomic testing and AI-guided personalised oncology care.
Integrating innovative technologies; including liquid biopsies, cancer vaccines and whole genome sequencing
Redesigning oncology pathways to deliver diagnostics, rehabilitation and follow-up care within community settings.
Accelerating treatment through digital integration, data-driven coordination and insights from precision and immunotherapy trials.

Register NowWhat’s New for 2026:

Morning and Afternoon Skill Clinics: immersive sessions providing delegates with practical templates for screening pathway redesign, genomic testing workflows and community-based cancer care models.
Lessons Learned Sessions: senior NHS leaders share where implementation plans faced challenges and what changes delivered success.
Peer Learning Circles: facilitated, topic-specific discussions connecting oncology teams, commissioners and innovation leads across the UK.
Action-Driven Case Studies: focused on the how: methods, processes and team structures that made progress possible.

Why Attend:

Build confidence through structured, applied learning and guided skill development.
Gain access to replicable frameworks for early diagnosis, genomic testing and localised cancer care delivery.
Hear directly from peers navigating similar workforce, innovation and integration challenges.
Leave with practical artefacts, toolkits, checklists and action plans ready to use within your organisation.
Strengthen your professional network through collaborative learning and best practice sharing across regions and specialties.

Who Would Benefit:
This summit is ideal for oncology service leads, cancer nurse specialists, diagnostic and genomic programme managers, community health directors and primary care leaders working to deliver more personalised, efficient and equitable cancer care. It will also benefit commissioners, clinical directors and innovation leads seeking practical insight into how to scale early detection, accelerate innovation and integrate cancer services into local care systems.
Suppliers, research partners and technology innovators will gain a clear understanding of the operational priorities shaping the next decade of NHS oncology transformation.

16th Annual World CB & CDx Summit
2026-10-05 00:00 - 2026-10-08 00:00 (America/New_York) | The Westin Boston Seaport District, 425 Summer Street, Boston, MA, 02210, United States
0000Days00Hrs00Min00SecAccelerating Complex Biomarkers, Novel & Multimodal Endpoints to Fuel Drug-Diagnostic Innovations from Bench-to-Bedside for Global Precision Medicine Access
As regulatory headwinds turn to tailwinds, precision medicine is shifting into a new gear.
Evolving FDA approaches to LDTs and 510(k) pathways are removing long-standing friction, coordinated Rx-Dx launches are gaining pace, ctDNA and MRD are advancing as clinically meaningful endpoints, and reimbursement expansion is improving access to high-value genomic testing. At the same time, innovation in multiplex assays, multi-omics platforms, liquid biopsy, digital pathology, spatial biology, and AI-powered diagnostics, are rapidly reshaping the IVD landscape.
Fueled by $60B+ in diagnostic deal-making and strategic partnerships, the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns as the industry’s esteemed end-to-end precision medicine forum. Convening 850+ senior leaders from biopharma, diagnostic, regulatory, healthcare, testing labs and multimodal communities, with expertise spanning the full value chain, gain the insights, partnerships and insider know-how to prime your team for continued clinical and commercial success.
With the race to bring scalable, accessible drug-diagnostic programs from bench-to-bedside heating up, join us in harnessing the speed, scale, and growing complexity of innovation happening in next-generation IVD platforms, multimodal data, and CDx development.
Register Now

Delve into the Brand-New Agenda

Free* Attendance for Representatives from Biopharma & Academia
Your Globally Leading Biomarker & Companion Diagnostics Forum
Access Numerous Strategic Rx-Dx Co-Development & Partnership Selection Panels
Partake in Multiple Biomarker Sessions Spanning Oncology, Hematology & Neurological, Chronic, Autoimmune & Rare Diseases
Discover Brand-New Case Studies on Digital Pathology, Multimodal Data & AI-Enabled Precision Medicine
Take Advantage of Unmatched, Exclusive Networking & Partnerships Opportunities

CAP 2026
2026-10-03 - 2026-10-06 | Wynn, Las Vegas, NV, United States
0000Days00Hrs00Min00SecCAP26 is where the future of pathology takes shape; where pathologists gather not just to gain knowledge, but to exchange ideas, build relationships, and reconnect around a shared vision.
The conversations are real, the education is practical, and the sense of belonging is unmistakable. You’re among colleagues who understand the stakes, the challenges, and what it means to be truly focused on patient outcomes.
Register NowThe CAP26 Abstract Program is a competitive program sponsored by the College of American Pathologists (CAP). The program is designed to promote a broad range of research in pathology. It offers pathologists and research scientists the opportunity to present original research to their peers in a poster presentation format.

BioTechX USA 2026
2026-09-29 - 2026-09-30 | Hynes Convention Center, Boston MA, USA, Boston, MA, United States
Data. AI. Precision. Innovation.
For Pharma, Healthcare & Partners
America’s most exciting biotechnology congress, bridging the gap between pharma, academia and clinicians to foster meaningful collaborations
BioTechX USA covers diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare. Now running for the third year, the event continues conversations on the East Coast, maintaining and fostering new relationships with key stakeholders in the healthcare industry.
The two-day event aims to bring together 1,500 global executives, 300 speakers, 100 sponsors and exhibitors, and 50 start-ups.
The BioTechX USA Congress features speakers from the top 50 pharmaceutical companies, biotechs, healthcare systems, and academic groups, with the goal of strengthening collaboration and networking opportunities.
With eight tracks of high-level content, the agenda covers everything from the use and management of multiomic data to the development of personalised therapies, as well as the generation of the data itself. There is also an opportunity to submit a scientific poster, which will be displayed throughout the two days of the event, providing an excellent platform to showcase research in biotechnology and genomics.
At a time when biotech is experiencing exponential growth, BioTechX USA brings together leaders from biotech, pharma, fast-growing industry start-ups, and established solution providers to offer insights into where the industry is heading next.
Register Now

MICCAI 2026
2026-09-27 - 2026-10-01 | Strasbourg Convention Centre, Pl. de Bordeaux, Strasbourg, 67000, France
0000Days00Hrs00Min00SecMICCAI 2026 (Medical Image Computing and Computer Assisted Intervention) is one of the world’s leading conferences in medical imaging, artificial intelligence, computer-assisted interventions, and healthcare innovation. Bringing together researchers, clinicians, engineers, and industry leaders, the conference showcases the latest advances in medical image analysis, machine learning, robotics, computer vision, and AI-driven healthcare technologies.
Following a recent announcement from the MICCAI Board, the 2026 conference will now take place in Strasbourg, France, having been relocated from its original venue in Abu Dhabi. The conference will continue to offer its renowned scientific programme, networking opportunities, and technology showcases, bringing the international medical imaging community together in person in Strasbourg.
Register Now

From digital transformation to AI readiness: University Medical Center Göttingen's Journey in Digital Pathology
2026-09-24 16:00 - 17:00 (Europe/Paris) | Online
0000Days00Hrs00Min00SecJoin Prof. Dr. med. Philipp Ströbel to learn how one of Germany’s pioneering academic pathology institutes transformed its pathology operations through digital pathology. The session covers UMG’s journey from early adoption to an optimized, fully digital workflow; lessons in workflow redesign and change management; and how digital pathology creates the foundation for AI adoption in a high-volume academic medical center.
Learning objectives

Describe the key drivers behind digital pathology adoption in a high-volume academic pathology environment.
Understand how digital pathology can improve workflow transparency, case management, collaboration, and operational efficiency.
Learn practical approaches for organizational change and user adoption.
Explore how a fully digital pathology workflow can support AI implementation and innovation.
Identify success factors for scalable, future-ready pathology infrastructure.

Register NowSpeakers
Prof. Dr. med. Philipp Ströbel
Director of the Institute of Pathology at University Medical Center Göttingen. Main customer speaker on UMG’s journey, workflow optimization, AI readiness and broader use of AI.
Bob Beertema
Marketing Lead, International Region, Philips. Host and moderator, guiding the discussion from the customer need and clinical experience rather than from product features.

38th European Congress of Pathology
2026-09-12 - 2026-09-16 | Stockholmsmässan, Mässvägen 1, Stockholm, 125 30, Sweden
0000Days00Hrs00Min00SecThe ESP Congresses are 5-day annual international pathology congresses by the European Society of Pathology and the largest gatherings of pathologists in Europe.
The aim is to provide an up-to-date scientific programme (e.g. keynote lectures, symposia, slide seminars, short courses, discussions) covering all major areas of diagnostic, translational, molecular and investigative pathology. Special emphasis will be put on both the recent discoveries and the reinforcement of close clinicopathological cooperation.
The 38th ECP will be delivered as a hybrid event with both live participation in Stockholm, Sweden and online participation. Speakers and Chairs will participate exclusively on-site.
Here is why you should attend:

All-in-one delegate fee (no sessions/courses to be paid extra)
The opportunity to meet pathologists from over 100 countries around the globe at the biggest pathology conference world-wide
A chance to meet your peers and evaluate research in front of the world’s leading pathology experts
Outstanding keynote lectures
Opportunity to interact with world-renowned speakers and chairs
A world-class platform to exhibit your products and services
Attractive industry sessions
Large part of content available on demand after the congress

Register NowThe core programme is being prepared with a strong input from the ESP Working Groups, ESP-affiliated Societies, Education and Trainee Subcomittees.
Expected educational outcome(s):

Familiarity with all histological and molecular approaches that are essential, according to current evidence, in the management of diseases.
Confidence in managing patients (screening, diagnosing, data reporting, and follow-up therapy) with neoplastic and non-neoplastic disorders that are identified, according to the existing evidence, by pathological procedures.
Identify major pitfalls and possible solutions in the diagnosis of certain clinical situations.
Discuss and integrate the most up-to date knowledge and recent research findings in the field of human pathology.
Identify opportunities for scientific collaborations worldwide.

KSMO 2026 - 19th Annual Meeting of the Korean Society of Medical Oncology
2026-09-02 - 2026-09-04 | Grand InterContinental Seoul Parnas, 521, Teheran-ro, Gangnam-gu, Seoul, Korea, Republic of
0000Days00Hrs00Min00SecAdvancing Cancer Care, Restoring Hope and Lives​
KSMO 2026—the 19th Annual Meeting of the Korean Society of Medical Oncology (KSMO) and the 2026 International Conference, held in conjunction with the 14th International Conference of the Federation of Asian Clinical Oncology (FACO), will bring together oncologists, researchers, clinicians, and healthcare professionals from around the world to explore the latest advances in cancer research and clinical oncology.
Held under the theme “Advancing Cancer Care, Restoring Hope and Lives,” the meeting will showcase the latest scientific discoveries, emerging therapies, multidisciplinary approaches to patient care, and innovations designed to improve outcomes for people living with cancer. Alongside a comprehensive educational programme, attendees will have the opportunity to collaborate, exchange ideas, and network with leading experts from across the international oncology community.
Register Now

Digital Diagnostics Summit 2026
2026-08-26 - 2026-08-28 | St.Regis Hotel, Park City, Park City, UT, United States
0000Days00Hrs00Min00Sec

Innovation in Action

Moving the needle from theory to actual, implemented, and viable digital pathology

Nestled at the base of the breathtaking Wasatch Mountains in the picturesque Park City, Utah, the Digital Diagnostic Summit stands as a beacon for innovation and adoption in digital pathology. Here, leading experts converge in a unique blend of professional collaboration and unconventional networking that go beyond the conference walls and into immersive experiences.

Register Now

5th Diagnexia Histopathology Symposium 2026
2026-08-20 - 2026-08-21 | The Queen’s College, Oxford, High Street, Oxford, OX1 4AW, United Kingdom
0000Days00Hrs00Min00SecDiagnexia is delighted to welcome you to The Queen’s College, Oxford for our fifth symposium. Across the two day symposium, a series of lectures and slide seminars will be delivered by leading names in the field addressing key problems, issues, and advancements, and a traditional Oxford college dinner.
Network
The symposium offers a unique chance to connect with peers, senior pathologists, and international experts — from interactive sessions to the Oxford college dinner — fostering collaboration and lasting professional relationships.
Learn
Through lectures and slide seminars led by leading experts, attendees gain practical insights into key challenges and emerging advancementt in histopathology
Be Inspired
The symposium brings together some of the most respected voices in histopathology, sparking new ideas, perspectives, and collaborations that inspire attendees to advance their practice and shape the future of the field.
Register for the 5th Diagnexia Histopathology Symposium 2026 and Computational Pathology Fundamentals to enjoy a 15% discount!
Find Out More and Register

Computational Pathology Fundamentals
2026-08-18 - 2026-08-19 | The Queen’s College, Oxford, High Street, Oxford, OX1 4AW, United Kingdom
0000Days00Hrs00Min00SecDon’t miss the 2026 Diagnexia Computational Pathology Fundamentals course — a rare opportunity to learn directly from leading experts, sharpen diagnostic skills, and exchange insights with peers in the historic setting of The Queen’s College, Oxford.
2-Day Course Agenda

DAY 1: Foundations of Computational Pathology
DAY 2: Advanced Topics and Clinical Applications

Register for Computational Pathology Fundamentals and the 5th Diagnexia Histopathology Symposium 2026 to enjoy a 15% discount!
Find Out More and Register

Meet the Next Generation of Concentriq: Pathology’s AI Platform for Precision Medicine
2026-07-28 17:00 - 18:00 (Europe/London) | Online
0000Days00Hrs00Min00SecThis webinar will start at 12pm EST, 5pm BST, 6pm CET, 9am PST
Diagnostic labs are being asked to do more than ever. Drug development teams are racing to find the right patients for increasingly complex therapies. The old playbook, a pathology platform with AI bolted on the side, can’t keep up.
Proscia built the next generation of Concentriq to be a different kind of platform. Concentriq Fifth Generation introduces intelligence that draws from clinical and scientific context to support experts throughout the decisions that define drug discovery and shape the future of diagnosis.
Join Proscia for the official first look. We’ll demo the platform live, hear from customers on the impact, and walk through how Concentriq helps labs deliver high-volume case reviews and R&D teams advance their programs.
In this session:

How Concentriq Fifth Generation brings intelligence into everyday case review and scientific workflows
What pathologists, lab leaders, and scientists can accomplish that wasn’t possible before
Real-world examples of intelligence accelerating case review, lab operations, biomarker discovery, and clinical development
A live look at Concentriq Fifth Generation in action

Whether you’re a pathologist, scientist, operations leader, or precision medicine leader, this is the session that changes how you think about what your pathology platform can do for you.
Register NowSpeakers
David West
Chief Executive Officer
Proscia
Coleman Stavish
Chief Technology Officer
Proscia
Dr. Cherub Kim
Director, Medical Affairs and Clinical Informatics Lead
Labcorp
Dr. Daniel Roberts
Medical Director of Digital Pathology
Cleveland Clinic
Dr. Amanda Hemmerich
Global Director of Digital Pathology Innovation
IQVIA Laboratories

TIA Centre Seminar Series – A Multimodal and Temporal Foundation Model for Virtual Patient Representations at Healthcare System Scale
2026-07-27 14:00 - 15:00 (Europe/London) | Online
0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions.
This seminar features Andrew Zhang from Harvard Medical School, Boston, USA.
Abstract
The field of medical AI has traditionally focused on isolated clinical domains, such as chest X-rays or pathology slides. These data modalities have the advantage of being plentiful, relatively standard in format, and information dense. But by looking at only individual snapshots of a patient’s medical journey, are we missing the forest for the trees? Outside of the world of curated medical imaging datasets, there are petabytes of clinical data existing in the electronic health record (EHR) as unstructured or semi-structured longitudinal events. These include diagnoses, symptoms, lab tests, clinical reports, medications, and more, each tied to a specific timepoint in the course of a patient’s healthcare journey. With our capacity to train increasingly larger and more powerful AI models, the next frontier is to build a virtual patient: a model that understands and makes predictions on the entire EHR. In this talk, I will introduce APOLLO, a major effort towards modeling whole patients: advancing the state of the art not only in data size (25 billion events from 7.2 million patients) but also in data breadth (structured data, clinical text, and images) and downstream capabilities. To evaluate the potential of this model, we created a large-scale benchmark consisting of over 300 patient retrieval and clinical forecasting tasks and showed that APOLLO patient embeddings generalize across medical domains and encode both retrospective and prognostic information about each patient. APOLLO has exciting applications not only in disease risk prediction but also as a multimodal medical search engine and unlocks the possibility of biomarker discovery from the entire EHR.
Register NowBio
Andrew Zhang is a 4th-year PhD student in the Harvard-MIT Health Sciences and Technology Program, working in the lab of Dr. Faisal Mahmood at Harvard Medical School. Prior to his PhD, Andrew studied cell biology and computer science at Harvard. His work centers on advancing self-supervised representation learning at multiple biological and temporal scales: from encoding a single pathology slide to encoding entire longitudinal medical histories.

Medical Image Understanding and Analysis (MIUA) 2026
2026-07-20 - 2026-07-22 | University College Dublin, Belfield, Dublin, Ireland
0000Days00Hrs00Min00SecThe Medical Image Understanding and Analysis (MIUA) is an international conference dedicated to the communication of research in image processing, analysis, and their applications in medical imaging and biomedicine. For the first time in MIUA history, we are hosting the conference in Ireland. As a rapidly growing field with increasing real-world impact, MIUA serves as the principal platform for sharing progress within the medical imaging community.
The conference welcomes researchers from diverse disciplines, including mathematics, computer science, bioinformatics, clinical practice, engineering, and biosciences. MIUA aims to foster collaboration and advance this multidisciplinary field by bringing together experts to share insights, disseminate findings, and discuss the latest advancements.
Designed to promote the growth and visibility of medical image understanding and analysis, MIUA encourages active engagement and collaboration across its broad audience, contributing to the development of innovative solutions in medical and biomedical imaging sciences.
Register NowMIUA covers many topics in medical imaging including:

Biomarker Discovery
Brain Imaging
Cancer Cardiac Imaging
Circulation and Microcirculation
Computational anatomy and physiology
Computed Tomography
Deep Learning
Dermatology
Image Interpretation
Image Guided Intervention
Image Physics
In-Vivo Intravital Imaging
Inflammation
Machine Learning
Magnetic Resonance Imaging
Microscopy
Multi Modal Image Analysis
Neurology
Novel Imaging Methods
Perception Modelling and Simulation
Positron Emission Imaging
Ophthalmology
Optical Imaging
Radiology
Texture Analysis
Tissue Perfusion
Ultrasound

NPIC Digital Pathology Webinar Series - Innovation into Practice - NPIC Digital Pathology Platform and Deployment Strategy
2026-07-14 03:00 - 04:00 UTC | Online
0000Days00Hrs00Min00SecThe National Pathology Imaging Co-Operative (NPIC) continues an exciting new series of free educational webinars on digital pathology topics.​

Learn first-hand about hot topics in clinical digital reporting, the digital laboratory, IT and informatics and get a chance to pose your questions to the experts! ​
Suitable for pathologists, biomedical scientists, informatics and IT professionals, managers and industry representatives.

In this session:

Find out about the NPIC technical platform for digital pathology!​
Hear about the opportunities and challenges of digital pathology deployment, and the NPIC approach.​
Pose questions to our speakers in our live Q and A session!

Register NowSpeakers:
Ian Mason
Programme Head for Digital Deployment & Business Services​

Waseem Akhtar
Portfolio Delivery Manager

Dr Bethany Williams
NPIC Knowledge and Skills Lead

QC at Scale: Moving Beyond Manual Review in Digital Pathology
2026-07-08 09:00 - 10:00 (Europe/London) | Online
0000Days00Hrs00Min00SecThis webinar will start at 10AM EDT, 7AM PDT, 4PM CET, 9am BST
As digital pathology volumes grow, manual quality control is struggling to keep pace. Slide defects like out-of-focus regions and missed tissue can slip through undetected, reaching pathologists’ queues and undermining diagnostic confidence, turnaround times, and AI readiness.
This webinar explores how AI-powered automation is transforming lab QC: catching issues early, reducing rework, and ensuring only the highest-quality images reach your pathologists.
What you’ll learn

Why manual QC breaks down at scale — and the hidden costs when it fails
How automated QA improves speed, consistency, and workflow efficiency across your lab
Why image quality is the foundation of every successful digital pathology and AI strategy

This webinar is ideal for…
Lab managers, QC staff, researchers and anyone involved in managing whole slide imaging workflows and their quality control
Register NowSpeaker
Katherine LatimerProduct Manager Digital PathologyBarco
Kat Latimer holds a Master of Engineering in Biomedical Engineering from Colorado State University and a BS in Biochemistry from the University of New Mexico. Her graduate research focused on tissue engineering and end-to-end medical device development. After spending several years at Indica Labs, she currently leads Barco’s digital pathology product efforts.

Advances in Screening and Early Detection in Urological Oncology
2026-07-08 | Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, United Kingdom
Advancing Urology Diagnostics Through Clinical Innovation
Join Source Cambridge Clinical Laboratories for an exclusive evening of education, discussion, and networking focused on the evolving landscape of urology diagnostics and patient care.
This specialist event will focus on the evolving role of advanced diagnostics in urology, exploring developments across early detection, screening, diagnosis, prognosis, and treatment decision-making.
Expert speakers will discuss the integration of innovative diagnostic approaches across both primary and secondary care settings, including insights into emerging biomarkers and specialist testing solutions such as Proclarix, alongside our wider urology portfolio.
The evening will provide an opportunity to connect with peers, share clinical perspectives, and discuss collaborative approaches to improving patient outcomes through more informed diagnostic strategies.
Spaces will be limited. Register your interest early to receive further event updates and priority access once registration opens.
Register Now

Path360 2026: The Convenzis NHS Pathology Strategy Conference South
2026-07-07 08:30 - 18:30 UTC | etc.venues, Prospero House, London, 241 Borough High St, London, SE1 1GA, United Kingdom
